Australia's largest stock trading and investment forum Australia's #1 stock forum

ATH

Click for more information

0.00%

0.5¢ alterity therapeutics limited

Peter Marks in FDA: accelerated approvals for rare diseases, page-7

First 7 Last

Share
Profile

Follow
Domy

493 Posts.

48

06/12/23

22:53

Post #: 71313724
Share

Originally posted by pivalde: ↑

https://endpts.com/qa-fdas-peter-marks-ready-to-encourage-more-accelerated-approvals-for-rare-diseases/

Marks: We’re going to be encouraging people in the direction of accelerated approval when they can, especially for rare diseases. Because for rare diseases, and especially things that are like neurodegenerative diseases, it could take a long time to get to clinical endpoints. I suspect we’ll continue to see more accelerated approvals in this rare disease, gene therapy space potentially also in the cell therapy space.

If ATH434 works in the randomized phase 2 study ( even in the open phase 2 study!) and when MSA is a rare, orphan disease, ATH should get ATH434 to the pharmacy, in my understanding. According to Stamler the price of ATH434 will be $100.000 - 150.000 / y., but it is still open.

Expand

This is supposed to be price sensitive news for ATH.

ATH Price at posting: 0.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

First 7 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $26.22M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$9.051K	1.899M

Buyers (Bids)

No.	Vol.	Price($)
51	61886501	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	29700836	14

View Market Depth

No.	Vol.	Price($)
51	61886501	0.004
46	56031315	0.003
13	26293014	0.002
13	93270102	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	29700836	14
0.006	16799598	23
0.007	17174670	18
0.008	14885875	17
0.009	6371000	8

Last trade - 10.23am 04/06/2024 (20 minute delay)


Last 0.5¢			Change 0.000 ( 10.0 %)
Open	High		Low	Volume
0.5¢	0.5¢		0.5¢	175000
Last updated 14.19pm 04/06/2024 ?

ATH (ASX) Chart